Crispr Therapeutics Viking Therapeutics: 2026 Stock Showdown
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Nearing retirement at 50? Discover wealth management strategies tailored to secure your financial future effectively.
21,324 articlesAs biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
SpaceX has joined the Nasdaq 100, triggering a wave of expected passive buying estimated at $27 billion as lockups un...
A downgrade and AI chip headlines pushed Broadcom stock lower today. Here’s what happened, what it could mean, and pr...
Federal agencies are deploying Anthropic’s Mythos to hunt bugs in critical code, a move that broadens AI’s role in na...
A congressional hearing places federal fraud losses close to $1 trillion annually, far surpassing GAO estimates, as e...
Fiserv announced the resignation of fiserv president dhivya suryadevara after less than a month in the role, with int...
BlackRock trims staking rewards in its ETHB ETF and warns that redemptions could take weeks. The move shifts ETHB clo...
AppLovin shares slipped in June as software peers faced headwinds. This in-depth look explains the catalysts, how the...
Tariff headlines and policy shifts are shaking crypto markets. This piece unpacks the sell-off, shows where prices mo...
Ethereum posts an 8% weekly gain, rebounding from June lows as institutions step back into the market and traders wei...
Outdoor gear players are showing renewed momentum as travel and camping trends rebound. This piece analyzes the leade...
Bitcoin sits in a bitcoin deep value zone as on-chain signals show ongoing selling pressure from long-term holders. T...